Posts Tagged ‘Side Effects’

Use of Antidepressants During Pregnancy May Alter Brain Development of Offspring, New Study Indicates

Monday, September 11th, 2023

Women taking antidepressants who are, or are planning to become, pregnant can discuss these risks with their physicians.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, September 7, 2023 — A new study indicates that expectant mothers’ use of antidepressants during pregnancy may negatively affect the brain development of their children, adding to the medical literature that has linked selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy to negative outcomes in offspring. SSRIs are the most frequently prescribed antidepressant for maternal depression.

Using brain imaging, researchers in the Netherlands measured the impact on the brain volume of 3,198 children whose mothers took SSRI antidepressants before or during pregnancy. The brain imaging was performed three times between the children’s ages of 7 to 15 and was compared to brain imaging of a control group of children whose mothers did not take antidepressants.

The results, reported in JAMA Psychiatry, indicated that, “compared with nonexposed controls, children prenatally exposed to SSRIs had less cerebral gray matter…which persisted up to 15 years of age,” the final age at which brain imaging was done in this study. Gray matter in the brain plays a significant role in mental functions, memory, emotions and movement. In the children exposed to SSRIs prenatally, negative effects were also observed in other brain tissues and brain structures the researchers had selected for examination. These effects did not last beyond early adolescence.

Previous research has linked SSRI antidepressants to many adverse effects during pregnancy and after birth.

SSRIs taken during the embryonic stage of development in pregnancy increases the risk of certain birth defects.  Expectant mothers using SSRIs incur an increased risk of miscarriage, premature birth, and their newborns being admitted to a neonatal intensive care unit.

Tapering and discontinuation of SSRIs before and during the early phase of pregnancy was advised by researchers who studied the withdrawal symptoms experienced by newborns. The symptoms of neonatal withdrawal syndrome include hypoglycemia, tremors, rapid breathing, and respiratory distress in newborns.

SSRI-exposed infants were found to have more impaired neurological functioning over the month following birth than non-exposed infants, including significantly poorer quality of movement, more signs of central nervous system stress, and lower self-regulation.

Taking SSRIs during pregnancy increases the risk of speech/language problems in offspring and has been linked to developmental delays.  

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a chemical imbalance in the brain – had no scientific basis. The study investigated whether evidence supported the theory that a low level of the brain chemical serotonin causes depression.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” the researchers wrote. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

Women taking antidepressants who are, or are planning to become, pregnant are encouraged to discuss these risks with their physicians.

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured hundreds of major cities worldwide to educate people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Foster Children Prescribed Psychiatric Drugs At Four Times the Rate of Non-Foster Children, New Study Finds

Monday, September 4th, 2023

Previous government recommendations for improved oversight of psychotropics in foster care have not resolved the overdrugging problem.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, August 24, 2023 — Despite government recommendations over more than a decade for more oversight of the psychotropic drugs given to foster children, a new study reveals that the powerful, mind-altering drugs are still disproportionately prescribed to these children as compared to non-foster youth.

Researchers at the Baylor College of Medicine in Houston, Texas, reviewed the Medicaid prescription claims of 397,340 children ages 1 to 18 to investigate the rates of psychotropic drug prescriptions for foster children as compared to youth not in foster care. Psychotropic drugs include antidepressants, antipsychotics, stimulants (ADHD drugs), antianxiety drugs, and mood stabilizers.

They found that foster children were prescribed at least one psychotropic drug at four times the rate (35%) of non-foster children (8%).

“Across all age groups, children in foster care on Medicaid were prescribed psychotropic medications disproportionately more than their non-foster peers on Medicaid,” concluded lead author Rachael J. Keefe, MD, MPH, FAAP, a pediatrician and associate professor of pediatrics-public health, writing in the Journal of Child and Adolescent Psychopharmacology.

The study comes at a time of renewed scrutiny of the amount of psychotropic drugs administered to children in the foster care system. These are children already traumatized by being removed from their homes, where they may have been abused or neglected. Giving them psychotropic drugs exposes them to the risk of having to also deal with drug side effects, some of the most serious of which are significant weight gain, uncontrollable restlessness (akathisia), uncontrollable muscle movements (tardive dyskinesia), heart problems, mania, violence, and suicidal thoughts and actions.

In April, a federal judge in Texas said he was appalled at “the massive amount of drugs that are given to these [foster] children” in psychiatric residential treatment facilities and expressed concern for the children’s safety. The judge was responding to a report on visits to 14 facilities housing foster children, which also showed a lack of proper monitoring of children taking the drugs.

Earlier this year, a federal class-action lawsuit was filed by several disability and civil rights organizations against the Maryland Department of Human Services and its Social Services Administration, alleging that up to 34% of Maryland foster children are prescribed psychotropic drugs, with over half of them prescribed more than one drug. The suit suggests that the drugs are being used on some children as a form of chemical restraint, according to a media report.

More than a decade ago, after an analysis of psychotropic drug use by Medicaid children in five states, the U.S. Government Accountability Office (GAO) issued a report in 2011 finding that foster children were prescribed psychotropic drugs at double to quadruple the rate of non-foster children. The GAO further found that hundreds of children were taking five or more psychotropic drugs, and thousands were prescribed doses higher than maximum levels recommended by the U.S. Food and Drug Administration (FDA). The GAO recommended government guidance be provided to increase oversight and protections for these children.

A seminal series of articles in 2014 in the San Jose Mercury News brought national attention to the problem again, detailing the high rate of psychotropic prescriptions continuing for children in the California foster care system.

The Office of Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS) investigated claims for antipsychotics, a large class of psychotropic drugs, paid for by Medicaid, the health provider for most foster children. Its 2015 report included findings of too many drugs or wrong doses being prescribed and poor monitoring of the children taking the drugs. The OIG recommended enhanced government oversight and reviews of psychotropics prescribed to children.

The OIG issued another report three years later, revealing that one in three children in foster care receiving psychotropic drugs did not receive required treatment planning or medication monitoring. The OIG again recommended better government oversight of psychotropic prescriptions.

Now, the new Texas study shows that the overdrugging of foster children is still occurring. Government recommendations for improved oversight to date have not resolved the problem.

The Citizens Commission on Human Rights urgently calls on state and federal governments to act to protect foster children from the massive overprescribing of psychotropic drugs and the physical and mental health risks the drugs carry.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

No Clear Benefit, But Serious Side Effects Common for Older People Taking Antidepressants, Study Finds

Monday, August 21st, 2023

Adverse effects from taking antidepressants are more common and serious for the elderly because they have more fragile health and take more medications.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, August 9, 2023 — A new review of recent medical literature on antidepressant use by older people with depression revealed no clear evidence of benefit, while adverse effects were found to be especially common and problematic. Alternative treatments for depression were advised.

The review was conducted to provide an overview of studies from the past decade of the benefit and harms of treatment of older persons with selective serotonin reuptake inhibitor (SSRI) antidepressants. The studies under review comprised depressed patients aged 55 and older who were taking SSRI antidepressants in comparison to control groups receiving placebos.

As reported in Mental Health Science, the evidence indicated that antidepressants have little, if any, benefit over placebos in this age group. There was even less evidence of depression remission.

“The evidence of the benefits of antidepressants in the elderly was weak and alternative treatments are advised,” wrote study author Michael Hvidberg, Ph.D., of the psychology department at the University of York in the U.K.

In the U.S., 15.6 million Americans aged 60 and older are prescribed antidepressants –
that’s one of every five (19%), with one in four (24%) of them women.

Adverse effects from taking the drugs are common and more serious among the elderly because they have more fragile health, deal with more medical issues, and take more medications. “Treatment with antidepressants may lead to more [adverse events] due to polypharmacy and age-related physiological changes,” Hvidberg writes, advising other treatment instead of the drugs.

Side effects of taking antidepressants include weight gain, nausea, insomnia, agitation, emotional blunting, sexual dysfunction, and even deepening depression. Psychiatrist Peter Breggin, M.D., describes antidepressants as neurotoxic because they harm and disrupt the functions of the brain and can cause abnormal thinking and behaviors, including anxiety, aggressiveness, loss of judgment, impulsivity, and mania, which can lead to violence and suicide.

Discontinuing antidepressants can bring on withdrawal symptoms, including electric shock-like sensations (“brain zaps” and “body zaps”), muscle spasms and tremors, hallucinations, confusion, irritability, and mania. One study found that more than half (56%) of people attempting to come off antidepressants experience withdrawal symptoms, with nearly half (46%) of them describing those symptoms as severe.

The new study’s finding of no clear benefit to patients from antidepressants is consistent with the results of a 2022 study, which found no clinically significant difference in measures of depression symptoms between adults treated with antidepressants and those taking placebos, whether over a shorter or longer time frame and regardless of the depression severity of the study participants.

Because the drugs have no strong evidence of benefit to patients, but carry the risks of significant side effects, researchers in another recent study advised primary care physicians not to prescribe antidepressants to depressed patients initially, but instead to recommend alternative approaches for treatment.  Similar guidance was issued in 2021 by the London-based National Institute for Health and Care Excellence, the organization that develops standards for health care practices in England.

One alternative approach to depression that has been repeatedly validated as effective in research studies is exercise. The results of one new study found that even exercise below levels of physical activity commonly recommended in health guidelines resulted in significant antidepressant benefits for older adults.

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a chemical imbalance in the brain – had no scientific basis.  The study investigated whether evidence supported the theory that a low level of the brain chemical serotonin causes depression.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” the researchers wrote. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Half of Depressed, Anxious Teens Recover Without Mental Health Treatment, Study Finds

Monday, August 7th, 2023

Research indicates the resilience of adolescents is effective and can avoid the ineffectiveness, harms and costs of pharmacological and psychological treatments.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, July 26, 2023 — A systematic review and meta-analysis on adolescents experiencing depression and/or anxiety reveals that half of them recovered on their own, without any mental health treatment.  Researchers say the result indicates that strengthening young people’s own resilience is key to their long-term mental health.

Noting that experiencing mental distress is common in the transition from adolescence to adulthood, a team of researchers reviewed previous studies to find the recovery rate of depressed and/or anxious adolescents who dealt with their teen angst without psychiatric drugs, psychotherapy, or other specific mental health treatment.  They found that within one year, half of depressed and/or anxious teens had recovered on their own.

“The findings suggest that after 1 year, about 54% of young people with symptoms of anxiety and/or depression recover without any specific mental health treatment,” according to the study’s lead author, Anna Roach, a PhD candidate at Queen Mary University of London.  Due to certain limitations of the study, the researchers suggest that the true rate of recovery is likely even higher. 

This result is an indication of teens’ ability to adapt and adjust to difficulties in life, “a sign of resilience, with young people bouncing back from their experience of distress,” the researchers wrote, reporting in the online peer-reviewed British medical journal, BMJ Open.

The high rate of recovery without involvement in the mental health system challenges the growing number of programs set up to screen and refer depressed or anxious teens to mental health practitioners for further evaluation and treatment.  As the researchers put it, “the question arises as to whether [teenagers] should routinely be considered for specialised treatments or whether one should wait with such decisions for a year, by which time about 54% are likely to have recovered without treatment.”

Instead of channeling young people into the mental health system, the study calls for new approaches to mental health care, noting also that psychiatric drugs and psychotherapy are both largely ineffective and costly.

Research on safe and effective alternative mental health treatment already exists.  For example, a 2023 study found that exercise is as effective in reducing symptoms of depression as antidepressant drugs or psychotherapy, regardless of the type or intensity of the exercise or whether done in a group or not.  Similarly, a 2020 study found exercise is effective in significantly reducing the symptoms of anxiety.

Many young people already avoid mental health treatment.  A recent study found that one in three depressed young adults preferred self-reliance instead of getting mental health treatment.  One in four cited concerns about being involuntarily committed to a psychiatric facility or having to take psychiatric drugs, while one in seven did not think mental health treatment would help them.

The most widely prescribed psychiatric drugs in the U.S. are antidepressants.  A recent study, published in World Psychiatry, advises doctors not to prescribe antidepressants as first-line treatment for most depressed patients because the benefit of the drugs is so small that it may not be clinically significant, and the drugs carry the risk of significant side effects.  Instead, the researchers suggest prescribing non-drug approaches first for the patients.

Some 45 million Americans are currently taking one or more antidepressants, including 5.7 million children and young adults under the age of 25, for whom the FDA requires a warning on the drug’s prescribing information of the increased risk of suicidal thoughts and actions.

Other adverse effects of antidepressants include weight gain, nausea, insomnia, agitation, emotional blunting and sexual dysfunction.  One recent study found that half of antidepressant users experience sexual problems, which can strain their relationships and lead to a worsening of their depression.   

Doctors have no clear guidance for tapering or discontinuing antidepressants, leaving their patients at greater risk of experiencing withdrawal symptoms that for many will be severe and incapacitating. 

A recent study found that more than 56% of people who attempt to come off antidepressants experience withdrawal effects, with nearly half (46%) of them rating the symptoms as ‘severe.’”

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a chemical imbalance in the brain – had no scientific basis.

“These studies all point to the desperate need for a drastic overhaul of the badly broken U.S. mental health system, which relies on the psychiatric drugs and practices that scientific research has found ineffective and harmful,” says Anne Goedeke, president of the National Affairs Office of the Citizens Commission on Human Rights.

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression, anxiety, or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health.  CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level.  The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

New Study Finds Troubling Mental and Physical Side Effects Are Main Reason Patients Stop Taking Antidepressants

Monday, July 31st, 2023

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, July 19, 2023 — A new study investigating why patients stop taking antidepressants found the most common reason given was the adverse physical and mental side effects experienced. The findings add to prior research revealing the troubling, and even dangerous side effects of these mind-altering psychotropic drugs.

Researchers in the U.S. and U.K. analyzed 667 reviews posted on the online health forum WebMD by users of seven common selective serotonin reuptake inhibitor (SSRI) antidepressants. The most common reason users gave for discontinuing antidepressants was the negative side effects they experienced.

Mental side effects were the adverse events most mentioned in the reviews, including apathy, anxiety, insomnia, loss of sexual drive, and suicidal ideation. These side effects were reported more often in the online posts than in the formal reporting systems set up by the U.S. Food and Drug Administration and the U.K. Medicines and Healthcare Products Regulatory Agency, leading the researchers to note that the online comments provide valuable, additional information for government drug regulatory agencies about the adverse effects of SSRIs.

“It is not merely feasible to collect data from online comments and reviews regarding SSRI medication changes, but…doing so can provide important supplementary information to reporting systems,” wrote lead author Su Golder, PhD, of the University of York in the U.K., reporting in JAMA Network Open.

Other top adverse events reported by SSRI users as reasons for discontinuing antidepressants were physical side effects, such as dizziness, drowsiness, headache, diarrhea, vomiting, weight gain, itchiness, excessive sweating, and sexual dysfunction.

“These results suggest that reasons for changes in SSRI use can be identified in online drug reviews and that adverse events mentioned may reflect those more salient to patients for discontinuing their medication,” according to Golder.

Though the study was intended to discover why SSRI users discontinue antidepressants so that ways to keep them on the drugs could be developed, the study provides additional evidence of the harm from the drugs that users contend with. Other recent research findings on the negative effects of antidepressants are much more disturbing.

A 2019 study indicated that the rate of attempted suicide was about 2.5 times higher in those taking antidepressants as compared to placebo. Those results were similar to a 2016 study that found antidepressants, given to healthy adult volunteers with no signs of depression, doubled their risk of suicidality and violence.

Antidepressant use has risen significantly over the past 15 years – and so have suicides and senseless acts of violence like mass shootings. In 2020, some 45 million Americans, or roughly one in seven, were taking antidepressants, up from 34 million in 2006. This 32% increase in users parallels the 35% increase in suicides in the U.S. over the same period. During the same time, many school shootings and other acts of senseless violence were committed by individuals taking antidepressants or in withdrawal from them.

A 2020 study found that half of antidepressant users experience sexual problems that can strain their relationships and lead to a worsening of their depression.  In a 2017 survey of antidepressant users, 44% of respondents reported the drugs negatively impacted their sex lives, 27% their ability to work or study, and 21% their relationships with friends or family.

For all the risk of serious side effects, recent research has found little, if any, benefit to antidepressants over placebos.  A 2022 study found no clinically significant difference in measures of depression symptoms between adults treated with antidepressants and those taking placebos, whether over a shorter or longer time frame and regardless of the depression severity of the study participants.

Another study in 2018 found that those who used antidepressants any time during the 30-year period of the study had an 81% greater chance of having more severe depression symptoms at the end of that time.

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a supposed chemical imbalance in the brain – had no scientific basis. The study investigated whether evidence supported the theory that a low level of the brain chemical serotonin causes depression.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” the researchers wrote. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Devastating Movement Disorders Caused by Antipsychotic Drugs Not Listed for Discussion at Psychiatrists’ Annual Meeting

Monday, July 17th, 2023

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, July 4, 2023 — None of the hundreds of meetings and sessions offered at the annual conference of the American Psychiatric Association in May was dedicated to discussing the potentially disabling and irreversible movement disorders, including tardive dyskinesia and akathisia, caused by the antipsychotic drugs the psychiatrists prescribe.

Tardive dyskinesia (TD) refers to the drug-induced, involuntary muscle movements that can develop over time from taking antipsychotic drugs, the class of drugs typically prescribed for symptoms of psychosis, mania, anxiety and depression. TD has also been linked to other classes of psychiatric drugs, including antidepressants, mood stabilizers and stimulants.

This psychiatric drug-induced physical disorder is characterized by repetitive, involuntary muscle movements of the face, lips, tongue, limbs, and torso that can range from a slight tremor, unnoticed by the patient, to uncontrollable movements of the entire body. More severe involuntary movements can become a disabling condition and can cause such embarrassment that the individual withdraws from social interaction.

“Tardive dyskinesia is a dreadful disorder caused by all the antipsychotic drugs,” according to psychiatrist Peter Breggin, MD. “People who suffer from it tend to become isolated from society and many become disabled.”

Currently, over 11 million Americans are taking antipsychotics, including more than 800,000 children and teens under the age of 18.

Studies have found that TD will eventually develop in 20%-30% of those taking antipsychotic drugs. Older age is a major risk factor for TD, with up to 50% to 60% of those over the age of 45 ultimately developing the movement disorder. This prevalence suggests that several million Americans may already be experiencing the symptoms of TD.

Race is also a risk factor for TD. A 2004 evaluation found antipsychotic-induced TD is more prevalent in African Americans than Americans of European descent.  This finding is even more consequential in light of the fact that African Americans are disproportionately diagnosed with psychosis and schizophrenia and then are likely to be prescribed antipsychotic drugs.

Even after discontinuing the drugs, TD may persist for years in a majority of patients who develop the condition, and it is often  permanent. A 2014 study at Emory University’s movement disorders clinic found that only about one in eight patients ever fully recover from TD.

Many taking antipsychotic drugs report they were not told of the risk of tardive dyskinesia by their doctor. A 2019 survey found that 58% of patients were not aware that the antipsychotics they were taking could cause TD. Among those suffering TD symptoms, 80% were emotionally distressed by their jerky movements, nearly half (47%) said it affected their job performance, and two-thirds reported a drop in self-esteem (68%) and self-confidence (64%).

Antipsychotics can also cause akathisia, a movement disorder characterized by restlessness and an inability to sit still. According to medical researcher Peter Gøtzsche, MD, “akathisia is one of the most dangerous harms of [antipsychotics] and depression drugs, as it predisposes [patients] to suicide, violence and homicide.” He says that psychiatrists typically misinterpret akathisia’s symptom of restless behavior as the patient’s need for a higher dose of the antipsychotics, which only worsens the situation.

One study found that half of all fights in a psychiatric ward stemmed from the akathisia related to the antipsychotic drugs the patients were taking, while another study revealed that 79% of mentally ill patients who attempted suicide suffered from the agitation of akathisia.

The continued prescribing of potentially disabling antipsychotic drugs is being further enabled by highly profitable drugs that were developed to treat TD, which patients take while they continue to stay on the antipsychotic or other drugs that are causing their TD. Drug companies manufacturing TD treatments have predicted sales of $1 billion to $2 billion per year. The TD-treatment drugs come with their own side effects, ironically including akathisia and agitation, as well as depression and suicidality.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antipsychotics and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of unwanted mental or behavioral symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Many Common Psychiatric Drugs Can Increase Patients’ Risk of Heat-Related Illness

Monday, July 10th, 2023

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, June 28, 2023/EINPresswire.com/ — Extreme heat, like the heat wave currently gripping the U.S. South, is especially dangerous for those prescribed many common psychiatric drugs, particularly antipsychotic drugs, that increase the risk of heat-related illness, ranging from the mild discomfort of heat cramps to the more serious symptoms of heat exhaustion and life-threatening heat stroke.

Many common psychiatric drugs can impair the body’s cooling mechanism or cause the people taking them to be less sensitive to signs of overheating, thus predisposing them to heat-related illness. Medical emergencies occur when the body’s temperature rises to dangerous levels and the body becomes unable to lower its temperature. Bodily damage, which can be fatal, occurs if steps are not taken to lower body temperature. One study found that taking psychiatric drugs nearly doubled the risk of death during a heat wave.

The elderly are even more susceptible to the risk of heat-related illness. The body’s temperature regulation is generally slower in older adults. Compared to young people, older adults also sweat less and radiate less heat, so the core body temperature rises more easily. The rate of hospitalization for heat stroke is significantly higher for older adults and their hospital stays are longer.

“In special risk situations such as heat waves, the risk/benefit ratio of psychotropic drugs which could interfere with body temperature regulation has to be carefully assessed, particularly in the elderly,” concluded French researchers, led by Karin Martin-Latry, PharmD, PhD, in a study published in European Psychiatry.

How many people taking psychiatric drugs end up with heat-related medical emergencies? Nobody knows.

“Due to the lack of research in the field, it is impossible to estimate the scale of the problem” of the interaction between drugs and heat, Ying Zhang, senior lecturer at the University of Sydney’s School of Public Health, told the Washington Post.

During periods of extreme heat, those taking antipsychotic drugs are at particular risk of heat stroke. Antipsychotics reduce sweating, the body’s natural means of cooling, as well as reduce the users’ behavior to cool themselves, like drinking more water or removing extra clothing. Even a short time in very hot weather can cause a rapid rise in body temperature for people on these drugs.

“Patients who are prescribed antipsychotics should be aware of the potentially fatal adverse events that can occur from these medications,” warned doctors in a recently published case report on antipsychotic drug-induced hyperthermia.

Stimulant drugs, like ADHD drugs, are known to raise body temperature, as well as interfere with the body’s ability to cool itself down. High summer temperatures can cause body temperatures that are already elevated by these drugs to go higher still.

Tricyclic antidepressants decrease sweating, along with inhibiting the body’s ability to regulate temperature, which can result in body temperature rising to dangerous levels during summer heat waves.

Selective serotonin reuptake inhibitor (SSRI) antidepressants can increase sweating while at the same time reducing thirst, which can lead to dehydration and heat illness in very hot weather.

Those taking psychiatric drugs should limit their exposure to summer heat and strenuous activity and drink plenty of water. Seek immediate medical attention for anyone showing signs of heat stroke, including confusion, unconsciousness, a rapid pulse, a high temperature, or red, hot, dry skin.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects from psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of unwanted mental or behavioral symptoms, which might otherwise be misdiagnosed as a psychiatric disorder and incorrectly treated.

WARNING: Anyone wishing to discontinue or change the dose of a psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

Psychiatrists at Annual Conference Warned That Antidepressants They Prescribe Can Deaden Patients’ Emotions

Monday, June 26th, 2023

New study confirms patients’ common complaints of antidepressants deadening their emotions and harming their sex life.

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, June 15, 2023 — A new study presented at the annual conference of the American Psychiatric Association informed psychiatrists that the emotional blunting caused by the antidepressants they prescribe is a significant and under-recognized side effect patients may suffer.

The current study reviewed 25 prior studies related to the problem of antidepressant-induced emotional blunting, described as “a persistent diminution in both positive and negative feelings,” which the patients differentiated as side effects of the drugs rather than symptoms of their depression.

The researchers concluded that “emotional blunting was a significant patient-reported concern with antidepressants.” That dulling of emotions could also be experienced as a change in personality or as not feeling like oneself.

A separate study earlier this year also found that participants given a selective serotonin reuptake inhibitor (SSRI) antidepressant experienced a reduction in positive emotions, along with a significant increase in sexual problems that the researchers suggested could be due to the reduced emotional pleasure.

Sexual dysfunction is reportedly experienced by many patients on antidepressants. Half of the antidepressant users who responded to a recent survey reported experiencing sexual problems they did not have before taking the drugs – problems that can strain relationships and lead to a worsening of the depression for which the drugs are being prescribed.

These findings add new credibility to patients’ common complaints of antidepressants deadening their emotions and sex life.

Worse still, the sexual disability can persist indefinitely, even after antidepressants are discontinued.  The condition, referred to as post-SSRI sexual dysfunction, has no definitive treatment, a fact many patients were not made aware of by their prescribers before starting antidepressants.

A key rationale for prescribing antidepressants in the first place – to fix a chemical balance in the brain – was recently found to be without scientific merit. Researchers conducted a comprehensive review of the research that had looked into whether a lack of the brain chemical serotonin causes depression and concluded there was no convincing evidence to support the theory.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” wrote the study’s lead author, Joanne Moncrieff. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

Also challenging the prescribing of antidepressants are the results of a study which found that taking antidepressants led to worse depression symptoms for patients years later. Patients who used antidepressants at any time during the 30-year period of the study had an 81% greater chance of experiencing more severe depression symptoms at the end of the period.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and emotional symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuses and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office
202-349-9267

Primary Care Doctors Advised Not to Prescribe Antidepressants to Patients on First Visit for Mild to Moderate Depression

Monday, June 5th, 2023

NEWS PROVIDED BY

Citizens Commission on Human Rights, National Affairs Office

WASHINGTON, DC, May 25, 2023 — Researchers are advising primary care doctors not to prescribe antidepressants to patients with mild to moderate depression on their first visit because of the drugs’ limited effectiveness and risks of significant side effects. Their conclusion, based on reviews of the available evidence on antidepressants, was published in World Psychiatry, the journal of the World Psychiatric Association.

Noting that most depressed patients in primary care settings have mild to moderate depression, the researchers cite recent research that found the benefit of antidepressants for such patients is so small that it may not be clinically significant. Instead, the researchers suggest non-drug approaches for these patients.

“Antidepressants should not be prescribed at the first visit if the patient has mild to moderate depression, because they have a limited efficacy and may have significant side effects,” according to lead author Bruce Arroll, professor in the Department of General Practice and Primary Health Care at the University of Auckland in New Zealand.

Even for a first visit to primary care by severely depressed patients, antidepressants may not be the best treatment, the researchers say. “The best strategy may be to reframe some of the negative cognitions of the patients and advise physical activity,” writes Arroll, with follow-up to track the patients’ results.

This advice is similar to guidance issued in 2021 by the organization that develops standards for health care practices in England. The London-based National Institute for Health and Care Excellence advised doctors not to routinely prescribe antidepressants as first-line treatment for people with less severe depression, but to offer a variety of non-drug treatment options and to respect the patients’ right to decline treatment.

Recent studies have found little, if any, benefit to antidepressants over placebos. Researchers led by Marc B. Stone of the FDA’s Center for Drug Evaluation and Research combined the results of 232 randomized controlled trials reported to the FDA from 1979 to 2016 that compared the effect of selective serotonin reuptake inhibitor (SSRI) antidepressants with placebos for patients with depression. Publishing their report in 2022 in the British Medical Journal, the researchers found that a benefit from antidepressants over placebos was limited to just 15% of the patients, while the other 85% experienced no benefit as compared to placebos. The placebo effect was powerful, with roughly two-thirds of the depressed patients given placebos getting better.

Another 2022 study found no clinically significant difference in measures of depression symptoms between adults treated with antidepressants and those taking placebos, whether over a shorter or longer time frame and regardless of the depression severity of the study participants.

Some 45 million Americans are currently taking one or more antidepressants, including 5.7 million children and young adults under the age of 25, for whom the FDA requires a warning on the drug’s prescribing information of the increased risk of suicidal thoughts and actions.

Other adverse effects of antidepressants include weight gain, nausea, insomnia, agitation, emotional blunting and sexual dysfunction. One recent study found that half of antidepressant users experience sexual problems that can strain their relationships and lead to a worsening of their depression.  In a survey of antidepressant users, 44% of respondents reported the drugs negatively impacted their sex lives, 27% their ability to work or study, and 21% their relationships with friends or family.

Those who used antidepressants any time during the 30-year period of another recent study had an 81% greater chance of having more severe depression symptoms at the end of the study.

Antidepressants may be prescribed to prevent suicides, but an examination of coroner inquests in which the decedents used antidepressants revealed that about half of the deaths were determined to be suicides.  One in eight of the deaths involved an overdose of antidepressants.

Discontinuing antidepressants can bring on serious symptoms during withdrawal, including electric shock-like sensations (“brain zaps” and “body zaps”), muscle spasms and tremors, hallucinations, confusion, irritability, and mania. One study found that more than half (56%) of people attempting to come off antidepressants experience withdrawal symptoms, with nearly half (46%) of them describing those symptoms as severe, and the symptoms can last for weeks or months.

More fundamentally, a landmark 2022 study questioned the prescribing of antidepressants at all, after finding the common reason for taking them – to correct a chemical imbalance in the brain – had no scientific basis. The study investigated whether evidence supported the theory that a low level of the brain chemical serotonin causes depression.

“The serotonin theory of depression has been one of the most influential and extensively researched biological theories of the origins of depression,” the researchers wrote. “Our study shows that this view is not supported by scientific evidence. It also calls into question the basis for the use of antidepressants.”

WARNING: Anyone wishing to discontinue or change the dose of an antidepressant or other psychiatric drug is cautioned to do so only under the supervision of a physician because of potentially dangerous withdrawal symptoms.

The Citizens Commission on Human Rights (CCHR) continues to raise public awareness of the risks of serious side effects and withdrawal symptoms from antidepressants and other psychiatric drugs, so that consumers and their physicians can make fully informed decisions about starting or stopping the drugs. CCHR supports safe and science-based non-drug approaches to mental health.

CCHR also recommends a complete physical examination with lab tests, nutritional and allergy screenings, and a review of all current medications to identify any physical causes of depression or other unwanted mental and behavioral symptoms, which might otherwise be misdiagnosed and incorrectly treated as a psychiatric disorder.

The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuses and restore human rights and dignity to the field of mental health. CCHR has been instrumental in obtaining 228 laws against psychiatric abuse and violations of human rights worldwide.

The CCHR National Affairs Office in Washington, DC, has advocated for mental health rights and protections at the state and federal level. The CCHR traveling exhibit, which has toured 441 major cities worldwide and educated over 800,000 people on the history to the present day of abusive and racist psychiatric practices, has been displayed at the Congressional Black Caucus Foundation Annual Legislative Conference in Washington, DC, and at other locations.

Anne Goedeke
Citizens Commission on Human Rights, National Affairs Office

1701 20th St. NW

Washington, DC 20009

(202) 349-9267

How to Cultivate Empathy

Monday, February 13th, 2023

Empathy is the capacity to understand or feel what another person is experiencing; to “walk in their shoes” so to speak.

[Derived from Ancient Greek ???????? (empatheia, “physical affection or passion”).]

We notice a huge amount of social media commentary about this concept, including a surfeit of pithy quotes. Wikipedia, for one example, discusses empathy extensively. We’re not going to go into it in such extraordinary depth, but we hope to add some useful observations.

One observation is that whenever there is so much back and forth discussion about a concept, there tends to also be major misunderstandings about it. We’d like to add our two cents.

Besides the obvious usefulness of empathy in the general social contexts of communication and understanding with others, there is also a practical application in marketing and public relations. For example, a product or service gets empathy by tying it in to one’s public using their local environment. This makes it more acceptable and improves its reach. As a local example, many products and services in the St. Louis metropolitan area are tied in name or picture with the Gateway Arch.

Some confuse empathy with compassion or sympathy. These are closely related but definitely different. Consult any good dictionary to understand the differences. (I recommend https://onelook.com/ to look up words online.)

One of the abiding concerns of commentary on empathy is how to teach it, how to develop it in a person when it is lacking. It is really a function of a living being’s awareness.

A large part of awareness training would be learning how to confront others and situations, while being open to all perceptions and remaining unrestimulated by noise and confusion. In this context, confront means to face without flinching.

People are not naturally aware of other people; they have to be drilled on observing others in order to bring about awareness. In many cases this normally occurs during one’s upbringing; in other cases this ability to observe may be lacking to greater or lesser degree and requires training. A century of psychological “know-best” that people are animals, not spiritual beings, has blunted this ability to observe in many unfortunate cases. Thus we get so much conversation on social media about how to develop empathy for others, which basically depends upon observing and being aware of others.

At the bottom of the scale of awareness there is delusion, in which a person sees one thing but thinks it is something else. This is more prevalent than one might suspect. Observational drills may not be enough to repair this failing.

Ways to Bring About a Heightened Sense of Empathy

A sensitivity to Human Rights is one way to cultivate empathy. Some notice that teaching about Human Rights brings about changes in attitude and behavior leading to more empathy toward others.

Another way to approach this is to recognize ways in which one’s awareness is turned to unawareness, and remedy those. A prime example of creating unawareness is psychiatric drugs.

These drugs create many of their effects by modifying the expression of neurotransmitters in the brain, which we call “playing Russian Roulette with your brain.”

Common and well-documented side effects of many psychiatric drugs include hallucinations, delusions, emotional disturbance, emotional numbing, confusion, akathisia (restlessness), brain damage, forgetfulness, memory lapses, hostility, aggressive behavior, and vision problems.

One can easily see that such side effects may contribute to one’s unawareness of what is going on around them, thus bringing about a destruction of empathy. The obvious remedy is to wean off taking these drugs and find non-drug alternatives for one’s troubles.

We hope these few observations have contributed to your understanding of empathy, and lead to a resurgence of your awareness of others.

Alien Mind Wipe